Real-world Difficulties in Conducting a Clinical Trial on Life-Style Modifications in Patients With Atrial Fibrillation

被引：0
|
作者：
Mohanty, Sanghamitra
Trivedi, Chintan
Gianni, Carola
Al-Ahmad, Amin
Burkhardt, John D.
Horton, Rodney
Sanchez, Javier
Hranitzky, Patrick
Gallinghouse, G. J.
Della Rocca, Domenico G.
Di Biase, Luigi
Natale, Andrea
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
Atrial fibrillation; Lifestyle;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
16466
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Do clinical trial cohorts reflect the complexities of real-world patients with chronic atrial fibrillation?
    Ball, J.
    Carrington, M. J.
    Stewart, S.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 955 - 955
  • [2] Stroke risk based on classification of atrial fibrillation: real-world vs clinical trial
    Ding, W. Y.
    Rivera-Caravaca, J. M.
    Marin, F.
    Roldan, V.
    Lip, G. Y. H.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 470 - 470
  • [3] Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real-World Data
    Buckley, Benjamin J. R.
    Harrison, Stephanie L.
    Gupta, Dhiraj
    Fazio-Eynullayeva, Elnara
    Underhill, Paula
    Lip, Gregory Y. H.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (23):
  • [4] Rivaroxaban and apixaban in patients with atrial fibrillation; a real-world data
    Aslan, Onur
    Yildirim, Sinan
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (04) : 948 - 957
  • [5] Real-world variability in dabigatran levels in patients with atrial fibrillation
    Chan, N. C.
    Coppens, M.
    Hirsh, J.
    Ginsberg, J. S.
    Weitz, J. I.
    Vanassche, T.
    Douketis, J. D.
    Schulman, S.
    Eikelboom, J. W.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (03) : 353 - 359
  • [6] Comparing the Real-World and Clinical Trial Bleeding Rates Associated with Oral Anticoagulation Treatment for Atrial Fibrillation
    Gue, Ying
    Bloomfield, Dan
    Freedholm, Debra
    Lip, Gregory Y. H.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [7] Suboptimal Management of Patients with Non-valvular Atrial Fibrillation: Real-world Clinical Setting
    Lau, Wallis C. Y.
    Chan, Esther W.
    Wong, Ian C. K.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 380 - 380
  • [8] Atrial fibrillation trial to evaluate real-world procedures for their utility in helping to lower stroke events: A randomized clinical trial
    Huang, Wen-Yi
    Lee, Meng
    Sung, Sheng-Feng
    Tang, Sung-Chun
    Chang, Kuo-Hsuan
    Huang, Yung-Sung
    Lee, Jiann-Der
    Lee, Tsong-Hai
    Jeng, Jiann-Shing
    Chung, Chang-Min
    Wu, Yi-Ling
    Hsieh, Tsung-Ta
    Ovbiagele, Bruce
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (03) : 300 - 310
  • [9] Rivaroxaban Precision Dosing Strategy for Real-World Atrial Fibrillation Patients
    Konicki, Robyn
    Weiner, Daniel
    Herbert Patterson, J.
    Gonzalez, Daniel
    Kashuba, Angela
    Cao, Yanguang Carter
    Gehi, Anil K.
    Watkins, Paul
    Powell, J. Robert
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (04): : 777 - 784
  • [10] Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
    Lin, Shin-Yi
    Kuo, Ching-Hua
    Yeh, Shin-Joe
    Tsai, Li-Kai
    Liu, Yen-Bin
    Huang, Chih-Fen
    Tang, Sung-Chun
    Jeng, Jiann-Shing
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (01) : 278 - 286
12345